© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
PTSD
Optimizing PTSD Treatment: The Role of Brexpiprazole and Sertraline in Future Guidelines
February 03, 2025
Brexpiprazole and sertraline showed promise for PTSD treatment in a recent study. Lead author, Lori Davis, MD, discusses clinical findings, treatment guidelines, and future research directions.
PTSD Treatment Advancements: Brexpiprazole-Sertraline Offers New Hope in Phase 3 Trial
January 29, 2025
Data showed that brexpiprazole plus sertraline significantly improved PTSD symptoms vs sertraline alone. Lead author, Lori Davis, MD, discusses more.
FDA to Convene Advisory Committee on Brexpiprazole-Sertraline for Adult PTSD
January 10, 2025
The adcomm meeting is expected to happen in the first half of 2025, and means the FDA expects to miss the target PDUFA date.
sNDA for Brexpiprazole/Sertraline Combination for PTSD Submitted for FDA Review
May 03, 2024
The sNDA for the brexpiprazole plus sertraline therapy is based on positive phase 2 and 3 clinical trials showing improvement in PTSD-specific scale scores.